Over the last 7 days, the United States market has dropped 2.6%, yet it remains up by 9.1% over the past year with earnings forecasted to grow by 14% annually. In this environment, identifying stocks that may be priced below their estimated worth can provide opportunities for investors seeking value in a fluctuating market.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name Current Price Fair Value (Est) Discount (Est) Mid Penn Bancorp (NasdaqGM:MPB) $26.65 $52.26 49% Burke & Herbert Financial Services (NasdaqCM:BHRB) $55.38 $108.54 49% Super Group (SGHC) (NYSE:SGHC) $8.41 $16.48 49% UMH Properties (NYSE:UMH) $16.47 $32.47 49.3% Advanced Flower Capital (NasdaqGM:AFCG) $4.72 $9.39 49.7% Excelerate Energy (NYSE:EE) $28.93 $57.38 49.6% TXO Partners (NYSE:TXO) $15.30 $29.94 48.9% ZEEKR Intelligent Technology Holding (NYSE:ZK) $29.17 $57.37 49.2% FinWise Bancorp (NasdaqGM:FINW) $14.445 $28.38 49.1% Clearfield (NasdaqGM:CLFD) $38.30 $74.77 48.8%

Click here to see the full list of 169 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

CompoSecure

Overview: CompoSecure, Inc. specializes in the design and manufacture of metal, composite, and proprietary financial transaction cards for both domestic and international markets, with a market cap of approximately $1.35 billion.

Operations: CompoSecure generates revenue through the production and design of metal, composite, and proprietary financial transaction cards for markets in the United States and abroad.

Estimated Discount To Fair Value: 38.8%

CompoSecure is trading at US$13.22, significantly below its estimated fair value of US$21.61, suggesting undervaluation based on discounted cash flow analysis. Despite a decline in Q1 sales to US$59.82 million from the previous year's US$104.01 million, net income rose to US$21.49 million, highlighting improved profitability prospects with forecasted earnings growth of 99.72% annually and expected profitability within three years amidst innovative product launches like the MetaMask metal payment card.

Upon reviewing our latest growth report, CompoSecure's projected financial performance appears quite optimistic. Take a closer look at CompoSecure's balance sheet health here in our report.NasdaqGM:CMPO Discounted Cash Flow as at May 2025

Genius Sports

Overview: Genius Sports Limited develops and sells technology-driven products and services for the sports, sports betting, and sports media industries, with a market cap of $2.38 billion.

Operations: The company generates revenue from its data processing segment, which amounts to $535.17 million.

Story Continues

Estimated Discount To Fair Value: 38.7%

Genius Sports, trading at US$10.1, is undervalued compared to its fair value of US$16.47 based on discounted cash flow analysis. Q1 2025 saw sales rise to US$143.99 million from US$119.72 million year-over-year, with net losses narrowing significantly to US$8.2 million from the previous year's loss of US$25.54 million. The company expects 21% revenue growth in 2025 and has launched innovative products like BetVision for Soccer, enhancing its market position and revenue potential through strategic partnerships and technological advancements.

Our growth report here indicates Genius Sports may be poised for an improving outlook. Navigate through the intricacies of Genius Sports with our comprehensive financial health report here.NYSE:GENI Discounted Cash Flow as at May 2025

Hess Midstream

Overview: Hess Midstream LP owns, operates, develops, and acquires midstream assets to provide fee-based services to Hess and third-party customers in the United States, with a market cap of $8.22 billion.

Operations: The company's revenue segments consist of Gathering at $814.60 million, Processing and Storage at $586.40 million, and Terminaling and Export at $120.90 million.

Estimated Discount To Fair Value: 46.1%

Hess Midstream, trading at US$38.16, is significantly undervalued with a fair value estimate of US$70.83 based on discounted cash flow analysis. Despite high debt levels and a dividend not fully covered by earnings or cash flows, the company's earnings are forecast to grow substantially at 32.5% annually over the next three years. Recent buyback announcements and reaffirmed guidance for 2025 underscore management's confidence in its financial trajectory amidst robust revenue growth expectations outpacing the market average.

Insights from our recent growth report point to a promising forecast for Hess Midstream's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Hess Midstream.NYSE:HESM Discounted Cash Flow as at May 2025

Where To Now?

Reveal the 169 hidden gems among our Undervalued US Stocks Based On Cash Flows screener with a single click here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Searching for a Fresh Perspective?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGM:CMPONYSE:GENI and NYSE:HESM.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments